About Adcendo

Adcendo is a global clinical-stage biotech company dedicated to developing transformative first and best-in-class antibody-drug conjugate (ADC) therapies for cancers with high unmet medical need.

We are headquartered in Copenhagen, Denmark, with operations in Copenhagen and in Boston, MA. Our team of highly specialized experts pioneer the development of groundbreaking novel ADCs through a combination of deep understanding of novel target biology, optimized linker payload technologies, and rationally designed clinical development plans.

We collaborate with a network of international scientific and clinical experts, technology & manufacturing partners, and life sciences investors.